Australia artificial intelligence (AI) in medical Imaging market size was valued at $18 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 36.9% from 2022 to 2030 and will reach $222 Mn. The market is segmented by AI technology, solution, modality, application, and end User. Due to rowing demand for advanced healthcare solutions, the demand for AI in medical imaging is rising across the Australia market. Some of the key players in this market are Harrison.ai (AUS), MaxQ AI (AUS), LBT Innovations (AUS), 4Dx Limited (AUS), Oneview Healthcare (AUS), Siemens Healthineers, GE Healthcare, Philips Healthcare, Fujifilm Holdings Corporation, Canon Medical Systems Australia, and others.
Market Executive Summary
Australia artificial intelligence (AI) in medical Imaging market size was valued at $18 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 36.9% from 2022 to 2030 and will reach $ 222. According to a report by the Australian Institute of Health and Welfare (AIHW), the total health expenditure in Australia for 2019-2020 was approximately $130.04 Bn. However, it is not specified how much of this expenditure was specifically for AI technology in medical imaging. AI in medical imaging is a growing field in Australia, with increased adoption of AI technologies in various medical imaging applications such as radiology, cardiology, and oncology. The demand for AI in medical imaging is driven by factors such as the increasing burden of chronic diseases, the aging population, and the need for more efficient and accurate diagnostic tools.
Artificial Intelligence (AI) in Medical Imaging in Australia has various demand and applications in different regions. For instance, the use of AI in medical imaging is widely accepted and implemented in the healthcare sector of NSW. It is being used in areas such as breast cancer screening, the detection of lung cancer, and brain imaging. AI is also being used to enhance the accuracy and speed of diagnosis and treatment planning.
In Addition, In Victoria, AI is being used in medical imaging for the detection and diagnosis of various diseases such as prostate cancer, breast cancer, and skin cancer. It is also being used to improve the quality and efficiency of radiology services. AI in medical imaging is being used in Queensland for the early detection of diseases such as lung cancer, liver cancer, and brain tumors. It is also being used to improve the accuracy of mammography and breast screening. Moreover, in Western Australia, AI in medical imaging is being used for the detection and diagnosis of various diseases such as lung cancer, prostate cancer, and breast cancer. It is also being used to improve the efficiency and accuracy of radiology services.
In South Australia, for the early detection and diagnosis of various diseases such as lung cancer, breast cancer, and prostate cancer AI is being used. It is also being used to improve the accuracy and speed of diagnosis and treatment planning. Overall, AI in medical imaging is gaining popularity and acceptance in various regions of Australia due to its potential to improve the accuracy and efficiency of diagnosis and treatment planning., AI in medical imaging is gaining popularity and acceptance in various regions of Australia due to its potential to improve the accuracy and efficiency of diagnosis and treatment planning. Hence, the demand for AI in medical imaging will increase during the forecast peiod.
Market Growth Drivers
February 2021: the Australian government announced a new funding initiative of AUD 45 million to support the development and adoption of new AI technologies in healthcare, including medical imaging.
August 2021: an Australian health tech startup called Harrison.ai secured a funding of AUD 129 million to expand its AI capabilities in medical imaging and healthcare analytics.
September 2021: researchers at the University of Queensland in Australia developed a new AI tool that can detect and classify skin lesions in medical images with high accuracy, potentially aiding in the early detection of skin cancer.
November 2021: the Australian government announced a new national data strategy to improve data sharing and integration across the healthcare system, which could facilitate the use of AI in medical imaging and other areas of healthcare.
December 2021: Australian medical imaging company I-MED Radiology Network partnered with AI firm VUNO to launch a new AI-powered tool for detecting lung cancer in medical images, which is expected to improve diagnostic accuracy and patient outcomes.
The Therapeutic Goods Administration (TGA), which is part of the Australian Government Department of Health, is responsible for regulating medical devices and pharmaceuticals in Australia. The TGA requires that all medical devices, including those that incorporate AI or machine learning technologies, undergo a rigorous process of testing and certification before they can be marketed and sold in Australia. Medical devices must also comply with the Essential Principles of Safety and Performance, which are set out in the Therapeutic Goods (Medical Devices) Regulations 2002.
In addition, the Australian Privacy Principles (APPs) apply to the use of personal data in healthcare, including data used in medical imaging. The APPs establish rules for the collection, use, and storage of personal data, including requirements for informed consent, data security, and the right to access and correct personal data.
Furthermore, the Australian Medical Association (AMA) has issued guidelines for the use of AI in healthcare, including medical imaging. The guidelines recommend that AI technologies should undergo rigorous testing and evaluation before being used in clinical practice, and that healthcare professionals should be trained in the use of these technologies. Overall, while there are no specific regulations in Australia that address the use of AI in medical imaging, healthcare providers and medical device manufacturers must comply with TGA regulations and the APPs when developing and implementing AI technologies in healthcare. It is also important to note that regulations and policies are subject to change over time, and healthcare professionals and industry stakeholders should stay up-to-date on any new developments or updates to existing regulations.
1. Report Description of the Australia Artificial Intelligence (AI) in Medical Imaging Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. Australia Artificial Intelligence (AI) in Medical Imaging Market Executive Summary
2.1 Australia Artificial Intelligence (AI) in Medical Imaging Market – Market Overview
2.2 Market Size, Growth Prospects, and Key findings
3. Market Dynamics of the Australia Artificial Intelligence (AI) in Medical Imaging Market
3.1 Market Growth Drivers Analysis
3.2 Market Restraints Analysis
4. Australia Artificial Intelligence (AI) in Medical Imaging Market Segmentation
4.1 By AI Technology
4.1.1 Deep Learning
4.1.2 Natural Language Processing (NLP)
4.2 By Solution
4.2.1 Software Tools/ Platform
4.3 By Modality
4.3.1 CT scan
4.3.4 Ultrasound Imaging
4.3.5 Nuclear Imaging
4.4 By Application
4.4.1 Digital Pathology
4.4.5 Lung (Respiratory System)
4.4.6 Breast (Mammography)
4.4.7 Liver (GI)
4.4.8 Oral Diagnostics
4.5 By End Use
4.5.1 Hospital and Healthcare Providers
4.5.3 Pharmaceuticals and Biotechnology Companies
4.5.4 Healthcare Payers
5. Australia Artificial Intelligence (AI) in Medical Imaging Market Share
5.1 Market Analysis, Insights, and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
7. Key Company Profiles
7.1 Company 1
7.1.2 Financial Performance
7.1.3 Product & Services
7.1.4 Strategic initiatives
7.2 Company 2
7.2.2 Financial Performance
7.2.3 Product & Services
7.2.4 Strategic initiatives
7.3 Company 3
7.3.2 Financial Performance
7.3.3 Product & Services
7.3.4 Strategic initiatives
7.4 Company 4
7.4.2 Financial Performance
7.4.3 Product & Services
7.4.4 Strategic initiatives
7.5 Company 5
7.5.2 Financial Performance
7.5.3 Product & Services
7.5.4 Strategic initiatives
8. Healthcare Policies and Regulatory Landscape
8.1 Healthcare Policies in the Australia
8.2 Regulatory Framework in the Australia
8.3 Pricing & Reimbursement Scenario in Australia Artificial Intelligence (AI) in Medical Imaging Market
9. Factors Driving Future Growth
9.1 New Trends and Development Australia Artificial Intelligence (AI) in Medical Imaging Market
9.2 Future Opportunities
10. Strategic Recommendations
By AI Technology
When compared to CT scans, magnetic resonance imaging can produce pictures that are free of imperfections. Due to its efficiency in obtaining details and better-quality pictures of soft tissues, the MRI is frequently seen as a superior alternative to X-rays. Utilizing optical coherence tomography, three-dimensional interactions between the retina and membranes are made possible in order to control the vitreoretinal disease.
The market is dominated by the digital pathology segment, which can be linked to pathologists' rising productivity. A validation tool for image analytics is provided by digital pathology, helping pathologists process more slides in less time. This facilitates early illness identification and quicker therapy initiation. AI and digital pathology also assist doctors in making patient-centered decisions. The oncology market is also expected to grow in popularity as more individuals become aware of cancer and its increased incidence in the public. Personalized therapy is made possible by artificial intelligence algorithms that identify and comprehend the nature of malignancies. The second section focUses on AI-driven diagnostic imaging for the heart, brain, breast, and mouth.
By End Use
The market is dominated by the healthcare sector. This is becaUse hospitals are widely dispersed and accessible; hence, many patients like hospitals. The market for medical imaging AI is also anticipated to benefit from favorable reimbursement regulations. During the anticipated time, diagnostic centers are anticipated to grow in popularity. This may be attributable to elements including rising patient awareness and a desire for diagnostic procedures and tests, all of which are fueling the market's expansion. Due to its ease in providing high-quality medical facilities in remote places, particularly rural ones, the ambulatory category is expected to develop at a quicker CAGR throughout the projection period. The availability of qualified surgeons and a surplAustralia of the necessary equipment are contributing to the expansion of the hospital market. Government assistance in emerging nations is likely to boost hospital infrastructure and technologies throughout the forecast period, which is anticipated to caUse the hospital segment to see growth.
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses